JP2007535490A5 - - Google Patents

Download PDF

Info

Publication number
JP2007535490A5
JP2007535490A5 JP2006541588A JP2006541588A JP2007535490A5 JP 2007535490 A5 JP2007535490 A5 JP 2007535490A5 JP 2006541588 A JP2006541588 A JP 2006541588A JP 2006541588 A JP2006541588 A JP 2006541588A JP 2007535490 A5 JP2007535490 A5 JP 2007535490A5
Authority
JP
Japan
Prior art keywords
antibody
monoclonal antibody
another embodiment
group
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006541588A
Other languages
English (en)
Japanese (ja)
Other versions
JP4991307B2 (ja
JP2007535490A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/039071 external-priority patent/WO2005052000A2/en
Publication of JP2007535490A publication Critical patent/JP2007535490A/ja
Publication of JP2007535490A5 publication Critical patent/JP2007535490A5/ja
Application granted granted Critical
Publication of JP4991307B2 publication Critical patent/JP4991307B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006541588A 2003-11-21 2004-11-19 抗il−20抗体および結合パートナーならびに炎症において用いる方法 Expired - Fee Related JP4991307B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US52413103P 2003-11-21 2003-11-21
US60/524,131 2003-11-21
US55585704P 2004-03-24 2004-03-24
US60/555,857 2004-03-24
PCT/US2004/039071 WO2005052000A2 (en) 2003-11-21 2004-11-19 Anti-il-20 antibodies and binding partners and methods of using in inflammation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011212399A Division JP2012036204A (ja) 2003-11-21 2011-09-28 抗il−20抗体および結合パートナーならびに炎症において用いる方法

Publications (3)

Publication Number Publication Date
JP2007535490A JP2007535490A (ja) 2007-12-06
JP2007535490A5 true JP2007535490A5 (https=) 2011-03-03
JP4991307B2 JP4991307B2 (ja) 2012-08-01

Family

ID=34636508

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006541588A Expired - Fee Related JP4991307B2 (ja) 2003-11-21 2004-11-19 抗il−20抗体および結合パートナーならびに炎症において用いる方法
JP2006541597A Pending JP2007537993A (ja) 2003-11-21 2004-11-19 抗il−20受容体抗体および結合パートナーならびに炎症において用いる方法
JP2011212399A Pending JP2012036204A (ja) 2003-11-21 2011-09-28 抗il−20抗体および結合パートナーならびに炎症において用いる方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2006541597A Pending JP2007537993A (ja) 2003-11-21 2004-11-19 抗il−20受容体抗体および結合パートナーならびに炎症において用いる方法
JP2011212399A Pending JP2012036204A (ja) 2003-11-21 2011-09-28 抗il−20抗体および結合パートナーならびに炎症において用いる方法

Country Status (8)

Country Link
US (3) US7393684B2 (https=)
EP (3) EP1697418A2 (https=)
JP (3) JP4991307B2 (https=)
AT (1) ATE447587T1 (https=)
CA (2) CA2545867A1 (https=)
DE (1) DE602004023965D1 (https=)
ES (1) ES2334140T3 (https=)
WO (2) WO2005052001A2 (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945511A (en) * 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
US6576743B1 (en) * 1997-11-26 2003-06-10 Zymogenetics, Inc. Mammalian cytokine-like polypeptide-10
US7122632B2 (en) * 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
ES2381650T3 (es) * 2000-08-08 2012-05-30 Zymogenetics, Inc. Receptores de citoquinas Zcytor11 solubles
EP1606316A2 (en) * 2003-03-24 2005-12-21 ZymoGenetics, Inc. Anti-il-20 antibodies and binding partners and methods of using in inflammation
JP4898691B2 (ja) 2004-10-22 2012-03-21 ザイモジェネティクス, インコーポレイテッド 抗il−22ra抗体および結合パートナー、ならびに炎症における使用法
EP2192132A3 (en) * 2005-02-08 2010-08-18 ZymoGenetics, Inc. Anti-IL-20, anti-IL22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation
US7611705B2 (en) * 2007-06-15 2009-11-03 National Cheng Kung University Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases
RU2011101969A (ru) 2008-06-30 2012-08-10 Ново Нордиск А/С (DK) Антитела к человеческому интерлейкину-20
WO2010042634A1 (en) * 2008-10-07 2010-04-15 National Cheng Kung University Use of il-20 antagonists for treating rheumatoid arthritis and osteoporosis
US7837994B2 (en) * 2008-10-07 2010-11-23 National Cheng Kung University Use of anti-IL-20 antibody for treating osteoporosis
US8012478B2 (en) * 2008-10-07 2011-09-06 National Cheng Kung University Use of anti-IL-20 antibody for treating stroke
US8454956B2 (en) 2009-08-31 2013-06-04 National Cheng Kung University Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies
JP2013525307A (ja) * 2010-04-16 2013-06-20 ナショナル チェン クン ユニバーシティ Il−20受容体活性の遮断による、il−20受容体を介するシグナリング経路に関連する障害の治療
US8535674B2 (en) 2010-06-15 2013-09-17 National Cheng Kung University Treating breast cancer and inhibiting cancer-associated bone loss with anti-IL-20 antibody
WO2013117751A2 (en) 2012-02-10 2013-08-15 Novo Nordisk A/S Methods related to treatment of inflammatory diseases and disorders
WO2013164440A1 (en) 2012-05-03 2013-11-07 Novo Nordisk A/S Methods related to treatment of inflammatory diseases and disorders
WO2014006230A1 (en) * 2012-07-06 2014-01-09 Novo Nordisk A/S Il-20 epitopes and il-20 ligands
US9221904B2 (en) 2012-07-19 2015-12-29 National Cheng Kung University Treatment of osteoarthritis using IL-20 antagonists
US8603470B1 (en) 2012-08-07 2013-12-10 National Cheng Kung University Use of IL-20 antagonists for treating liver diseases
US8852588B2 (en) 2012-08-07 2014-10-07 National Cheng Kung University Treating allergic airway disorders using anti-IL-20 receptor antibodies
CN114176586B (zh) * 2012-12-14 2025-01-07 明德拉公司 用于检测和获取生物标志物的方法和装置
US20140314741A1 (en) * 2013-04-18 2014-10-23 Developmen Center For Biotechnology Human Antibody against Interleukin-20 and Treatment for Inflammatory Diseases
CN112961062A (zh) 2014-04-04 2021-06-15 沙特基础工业全球技术有限公司 最小化乙醇胺产物流股中的水含量
CN106164043A (zh) 2014-04-08 2016-11-23 沙特基础工业全球技术有限公司 最小化乙醇胺产物流股中的水含量
EP3148965A1 (en) 2014-05-27 2017-04-05 SABIC Global Technologies B.V. Production of tea 85% directly without blending with pure cut of dea 99%
EP3148964A1 (en) 2014-05-30 2017-04-05 SABIC Global Technologies B.V. Improved quality and color of ethanolamine product streams by reduced temperature at the triethanolamine column
PT3151921T (pt) 2014-06-06 2019-11-21 Bristol Myers Squibb Co Anticorpos contra recetor do fator de necrose tumoral induzido por glicocorticoide e utilizações dos mesmos
CA2950499A1 (en) * 2014-07-03 2016-01-07 Immunoqure Ag Human-derived anti-human il-20 antibodies and assay for the identification of anti-cytokine antibodies
CA2988115A1 (en) 2015-06-03 2016-12-08 Bristol-Myers Squibb Company Anti-gitr antibodies for cancer diagnostics
BR112018010172A2 (pt) 2015-11-19 2018-11-21 Bristol Myers Squibb Co anticorpos contra receptor de fator de necrose de tumor induzido por glicocorticoide (gitr) e usos dos mesmos
WO2017202813A1 (en) * 2016-05-24 2017-11-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of pulmonary bacterial infections
US9982043B2 (en) 2016-06-03 2018-05-29 National Cheng Kung University Use of IL-20 antagonists for treating pancreatic cancer
US20180057564A1 (en) * 2016-08-23 2018-03-01 Clover Biopharmaceuticals Antagonists of il-20 family of cytokines and their use
WO2018200620A1 (en) 2017-04-25 2018-11-01 National Cheng Kung University Use of il-20 antagonists for treating eye diseases
CN110869392A (zh) 2017-05-16 2020-03-06 百时美施贵宝公司 用抗gitr激动性抗体治疗癌症
JP7258329B2 (ja) * 2018-09-01 2023-04-17 国立大学法人神戸大学 連続式振動流バッフル反応装置及び反応法
US12460009B2 (en) 2019-09-04 2025-11-04 Inserm (Institut National De La Sante Et De La Recherche Medicale) Monoclonal antibodies specific for IL20-Rb, encoding nucleic acids thereof and methods of use thereof to treat bacterial-induced exacerbation of chronic obstructive pulmonary disease

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208021A (en) * 1987-10-05 1993-05-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of preparing diphtheria immunotoxins
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US20020099179A1 (en) * 1989-12-21 2002-07-25 Linda K. Jolliffe Cdr-grafted antibodies
US5436155A (en) 1991-12-31 1995-07-25 Arch Development Corporation Isolated DNA encoding a somatostatin receptor
US5789192A (en) 1992-12-10 1998-08-04 Schering Corporation Mammalian receptors for interleukin-10 (IL-10)
GB2315386B (en) 1996-07-13 2000-10-18 Motorola Ltd Improved flow control in cellular radio networks
US5985614A (en) * 1996-08-30 1999-11-16 Human Genome Sciences, Inc. Polynucleotides encoding interleukin-19
ATE424410T1 (de) 1996-08-30 2009-03-15 Human Genome Sciences Inc Interleukin-19.
DE19650541C2 (de) 1996-12-05 1999-05-12 Siemens Ag Verfahren zur Ermittlung eines ersten Referenzschriftzugs anhand mehrerer Musterschriftzüge
US5945511A (en) 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
WO2000078961A1 (en) 1999-06-23 2000-12-28 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP0981548A4 (en) * 1997-04-30 2005-11-23 Enzon Inc GLYCOSYLATABLE SINGLE CHAIN ANTIGEN-BINDING PROTEINS, MANUFACTURE AND USE THEREOF
AU8571198A (en) 1997-07-16 1999-02-10 Human Genome Sciences, Inc. Interleukin-20
US6486301B1 (en) 1997-07-16 2002-11-26 Human Genome Sciences, Inc. Interleukin-20
US5965704A (en) 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
AU8899298A (en) 1997-08-06 1999-03-01 Zymogenetics Inc. Lipocalin homologs
US6576743B1 (en) 1997-11-26 2003-06-10 Zymogenetics, Inc. Mammalian cytokine-like polypeptide-10
CN1247780C (zh) * 1997-11-26 2006-03-29 津莫吉尼蒂克斯公司 哺乳动物细胞因子样多肽-10
EP1047781B1 (en) 1998-01-23 2004-07-28 Immunex Corporation Il-18 receptors
US6586228B1 (en) 1998-03-09 2003-07-01 Schering Corporation Polynucleotides encoding DIRS1
WO1999046379A2 (en) 1998-03-09 1999-09-16 Schering Corporation Human receptor proteins; related reagents and methods
JP3868740B2 (ja) 1998-03-10 2007-01-17 ジェネンテック・インコーポレーテッド 新規なポリペプチド及びそれをコードする核酸
US6982320B2 (en) 1998-03-19 2006-01-03 Human Genome Sciences, Inc. Cytokine receptor common gamma chain like
AU5203199A (en) 1998-05-26 1999-12-13 Procter & Gamble Company, The Chimeric molecules comprising an extracellular ligand binding domain of a receptor and an ige fc or constant region, and their use in an assay system
NZ531664A (en) 1998-09-01 2005-07-29 Genentech Inc Pro1317 polypeptides and sequences thereof with homology to the semaphorin B glycoprotein family
WO2000031278A1 (en) 1998-11-25 2000-06-02 Zymogenetics, Inc. Zace1: a human metalloenzyme
EP1141008A1 (en) 1998-12-31 2001-10-10 Millennium Pharmaceuticals, Inc. Class ii cytokine receptor-like proteins and nucleic acids encoding them
AU5047600A (en) 1999-05-27 2000-12-18 Schering Corporation Mammalian interleukin-10 homologs: il-d110 and il-d210
US6897292B2 (en) 1999-12-03 2005-05-24 Zymogenetics, Inc. Human cytokine receptor
WO2001046261A1 (en) * 1999-12-23 2001-06-28 Zymogenetics, Inc. Method for treating inflammation
US6610286B2 (en) * 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
ES2381650T3 (es) * 2000-08-08 2012-05-30 Zymogenetics, Inc. Receptores de citoquinas Zcytor11 solubles
JP4908723B2 (ja) * 2000-09-15 2012-04-04 ザイモジェネティクス, インコーポレイテッド 炎症を治療するための方法
EP1390060A2 (en) 2001-01-26 2004-02-25 Eli Lilly And Company Use of lp82 to treat body weight disorders
WO2002070001A2 (en) * 2001-02-28 2002-09-12 Eli Lilly And Company Use of lp82 to treat hematopoietic disorders
AU2002245652A1 (en) 2001-03-09 2002-09-24 Zymogenetics, Inc. Soluble heterodimeric cytokine receptor
DE10154579A1 (de) 2001-11-07 2003-05-28 Medigene Ag Topikale Verwendung von Cytokinen und Chemokinen zur Behandlung von viralen oder mykotischen Hauterkrankungen oder Tumorerkrankungen
CA2467723C (en) 2001-12-17 2011-09-27 Zymogenetics, Inc. Method for treating cervical cancer
EP1546358A4 (en) 2002-03-22 2006-06-07 Zymogenetics Inc ANTI-IL-TIF ANTIBODIES AND METHOD FOR USE ON INFLAMMATION
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
JP4053444B2 (ja) * 2003-03-07 2008-02-27 シャープ株式会社 携帯可能な多機能電子機器
EP1606316A2 (en) 2003-03-24 2005-12-21 ZymoGenetics, Inc. Anti-il-20 antibodies and binding partners and methods of using in inflammation
JP4898691B2 (ja) * 2004-10-22 2012-03-21 ザイモジェネティクス, インコーポレイテッド 抗il−22ra抗体および結合パートナー、ならびに炎症における使用法
JP2008106946A (ja) * 2005-02-10 2008-05-08 Matsushita Electric Ind Co Ltd 冷凍サイクル装置
CA2914170C (en) * 2006-09-08 2018-10-30 Abbvie Bahamas Ltd. Interleukin-13 binding proteins
RU2011101969A (ru) * 2008-06-30 2012-08-10 Ново Нордиск А/С (DK) Антитела к человеческому интерлейкину-20

Similar Documents

Publication Publication Date Title
JP2007535490A5 (https=)
CY2019029I2 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
LTC2567976I2 (lt) Antikūnai prieš CD38 antigeną, skirti išsėtinės mielomos gydymui
EP1607404A4 (en) MONOCLONAL ANTIBODY AND HYBRIDOM THAT PRODUCES THIS
LTC2305817I2 (lt) Anti-IL-12 antikūnai, kompozicijos, būdai ir panaudojimas
DK1578397T3 (da) Humane monoklonale antistoffer mod CD25
CY2012019I2 (el) Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20
JP2012507294A5 (https=)
JP2005526058A5 (https=)
TW200636064A (en) Anti-respiratory syncytial virus antibodies, antigens and uses thereof
DE60222658D1 (de) Monoklonaler anti-cd-40-antikörper
NL1027975A1 (nl) Antilichamen tegen MAdCAM.
CY2014038I1 (el) Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
SI2311873T1 (sl) M-CSF-specifična monoklonska protitelesa in njihova uporaba
ATE517340T1 (de) Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren
JP2005516606A5 (https=)
ITRM20040586A1 (it) Epitopi antigenici dell'interleuchina-21, anticorpi relativi e loro uso in campo medico.
JP2004523538A5 (https=)
ITRM20040105A1 (it) Anticorpo monoclonale antitenascina umana.
FI20020807A0 (fi) Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita
JP2004526429A5 (https=)
FI20011055A0 (fi) Heveiiniä sitovat monoklonaaliset vasta-aineet
DK1503799T3 (da) Immunogent, monoklonalt antistof
EP1483292A4 (en) MONOCLONAL ANTIBODIES WITH CROSS-REACTION AGAINST BACTERIAL COLLAGEN BINDING PROTEINS
ITTO20010762A0 (it) Anticorpi monoclonali anti-ssrp-1 ed ibridomi producenti tali anticorpi.